Philip Morris Prepares to Launch IQOS in Austin, Texas

PMI by 2FIRSTS.ai
Mar.29.2024
Philip Morris Prepares to Launch IQOS in Austin, Texas
Philip Morris International is preparing to launch its flagship tobacco device IQOS in Austin, Texas, marking its debut in the US.

According to a report from Yahoo Finance on March 29th, tobacco giant Philip Morris International is preparing to launch its flagship heated tobacco device IQOS in the capital city of Texas, Austin. This indicates that Austin will be the first city in the United States where the company will pilot this product.

 

Investors are watching to see if Philip Morris International (PMI) can create a heated tobacco market in the United States, where e-cigarettes currently dominate. The country provides PMI with a large base of new users and potential new sources of revenue. IQOS may bring about a transformation as it aims to generate more income from products other than cigarettes.

 

According to reports, PMI has announced plans to launch the device in four cities across two states in the United States. The first city is expected to be targeted in the second quarter of this year, with a more extensive rollout possibly happening by 2025. However, the company has not disclosed further details, including the specific cities and states they are targeting. However, a job advertisement on LinkedIn has revealed that the company is preparing for the release of IQOS in Austin, Texas.

 

PMI is projected to spend the majority of its $10.7 billion tobacco alternative budget between 2008 and 2022 on the development of IQOS. However, this has not allowed IQOS to lead in the U.S. market. It is expected that by 2030, IQOS will account for 10% of tobacco and heated tobacco unit sales in the United States.

 

Up to now, besides IQOS managed by PMI's former parent company, Altria, and another product offered on a small scale by British American Tobacco, there have been basically no heated tobacco products in the US market.

 

PMI paid $2.7 billion to acquire the rights to sell IQOS in the United States in 2022 from Altria. British American Tobacco expressed doubt about the potential of this category in the country, as e-cigarettes and other alternatives have already matured in the market.

 

Brett Cooper, managing partner and analyst at stock research firm Consumer Edge, stated that Texas offers an interesting test market due to its wide-ranging population demographics, from very rural to highly urbanized. He added that diverse cities like Austin, Houston, and Dallas provide opportunities to reach a broad range of consumer groups.

 

According to data from the Appeals and Centers for Disease Control and Prevention (CDC), Texas has relatively low tobacco taxes. The data shows that in September 2023, the cigarette consumption tax rate in Texas was $1.41 per pack, much higher than Missouri's 17 cents, but also much lower than New York's tax rate of over $5 per pack.

 

In January, Texas implemented a new law regarding e-cigarettes, restricting devices that resemble candies or fruit juices, or contain symbols or images of celebrities targeted at minors, or depict cartoon characters or fictional characters.

 

Prior to the release of IQOS, the company also established its lobbying power nationwide in the United States. The company aims to have two-thirds of its revenue come from "smoke-free" products.

 

We welcome news tips, article submissions, interview requests, or comments on this piece.

Please contact us at info@2firsts.com, or reach out to Alan Zhao, CEO of 2Firsts, on LinkedIn


Notice

1.  This article is intended solely for professional research purposes related to industry, technology, and policy. Any references to brands or products are made purely for objective description and do not constitute any form of endorsement, recommendation, or promotion by 2Firsts.

2.  The use of nicotine-containing products — including, but not limited to, cigarettes, e-cigarettes, nicotine pouchand heated tobacco products — carries significant health risks. Users are responsible for complying with all applicable laws and regulations in their respective jurisdictions.

3.  This article is not intended to serve as the basis for any investment decisions or financial advice. 2Firsts assumes no direct or indirect liability for any inaccuracies or errors in the content.

4.  Access to this article is strictly prohibited for individuals below the legal age in their jurisdiction.

 

Copyright

 

This article is either an original work created by 2Firsts or a reproduction from third-party sources with proper attribution. All copyrights and usage rights belong to 2Firsts or the original content provider. Unauthorized reproduction, distribution, or any other form of unauthorized use by any individual or organization is strictly prohibited. Violators will be held legally accountable.

For copyright-related inquiries, please contact: info@2firsts.com

 

AI Assistance Disclaimer

 

This article may have been enhanced using AI tools to improve translation and editorial efficiency. However, due to technical limitations, inaccuracies may occur. Readers are encouraged to refer to the cited sources for the most accurate information.

We welcome any corrections or feedback. Please contact us at: info@2firsts.com

Product | Full-screen display and 10K puffs: IVG launches new Pro-series pod vape in the UK
Product | Full-screen display and 10K puffs: IVG launches new Pro-series pod vape in the UK
E-cigarette brand IVG has recently rolled out the IVG Pro 2 across several UK online retailers. The device is compatible with IVG Pro pods and comes in 33 flavours with nicotine strengths of 0mg, 10mg and 20mg. Channel listings show a 2ml prefilled pod paired with a 10ml refill container, with pricing around £9.99.
Feb.02 by 2FIRSTS.ai
Korea’s MFDS sets 2026 plan to manage and disclose harmful constituents in tobacco products
Korea’s MFDS sets 2026 plan to manage and disclose harmful constituents in tobacco products
South Korea’s Ministry of Food and Drug Safety (MFDS) said it has established its 2026 work plan to systematically manage harmful constituents in tobacco products and disclose related information under the Tobacco Harmfulness Management Act, which took effect in November 2025.
Jan.16 by 2FIRSTS.ai
Perak to stop issuing new vape licences, aiming for a phased “zero sales” outcome after October
Perak to stop issuing new vape licences, aiming for a phased “zero sales” outcome after October
Perak executive councillor Datuk Sivanesan said the state government aims to progressively reach a “zero” level of vape sales no later than after October, noting vape operators were clearly informed in October 2025.
Jan.05 by 2FIRSTS.ai
Kyrgyzstan: Jogorku Kenesh committee sends draft vape ban bills back for revisions
Kyrgyzstan: Jogorku Kenesh committee sends draft vape ban bills back for revisions
Kyrgyzstan Jogorku Kenesh committee on labor, health, women’s affairs and social issues decided to withdraw for revision two draft laws related to banning electronic nicotine delivery systems and e-cigarettes in Kyrgyzstan.
Jan.14 by 2FIRSTS.ai
Mexico City hands over 50,376 vapes and e-cigarettes for destruction, valued at USD 570,000
Mexico City hands over 50,376 vapes and e-cigarettes for destruction, valued at USD 570,000
Mexico City Head of Government Clara Brugada handed over 50,376 vapes and e-cigarettes in the Zócalo for final destruction. The report puts the value at 10 million pesos (about USD 570,000) and says the goods were seized from a stall and a warehouse in the Historic Center, with one person detained because selling these products is illegal.
Jan.19 by 2FIRSTS.ai
FDA Commissioner Stresses “Predictability” as Science Chief Addresses Industry Uncertainty
FDA Commissioner Stresses “Predictability” as Science Chief Addresses Industry Uncertainty
FDA Commissioner Marty Makary briefly appeared at the February 10 PMTA roundtable, underscoring the importance of regulatory predictability. At the close of the session, Office of Science Director Matthew Farrelly responded to industry concerns over review uncertainty, stating the agency will issue a written summary of feedback, while reiterating that no fixed quantitative risk benchmark governs authorization decisions.
Feb.11